title: Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.
authors.forename: Juergen
authors.initials: J
authors.lastname: Rech
authors.forename: Monika
authors.initials: M
authors.lastname: Ronneberger
authors.forename: Matthias
authors.initials: M
authors.lastname: Englbrecht
authors.forename: Stephanie
authors.initials: S
authors.lastname: Finzel
authors.forename: Julia
authors.initials: J
authors.lastname: Katzenbeisser
authors.forename: Karin
authors.initials: K
authors.lastname: Manger
authors.forename: Bernhard
authors.initials: B
authors.lastname: Manger
authors.forename: Georg
authors.initials: G
authors.lastname: Schett
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D008297:Male; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors*; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007375:Interleukin-1; D019947:Receptors, Interleukin-6; D014409:Tumor Necrosis Factor-alpha; C502936:tocilizumab